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ttp://dx.doi.org/10.1016/j.ajpath.2014.02.006Laminin a1 (LAMA1), a subunit of the laminin-111 basement membrane component, has been impli-
cated in various biological functions in vivo and in vitro. Although LAMA1 is present in kidney, its roles
in the kidney are unknown because of early embryonic lethality. Herein, we used a viable conditional
knockout mouse model with a deletion of Lama1 in the epiblast lineage (Lama1CKO) to study the role of
LAMA1 in kidney development and function. Adult Lama1CKO mice developed focal glomerulosclerosis
and proteinuria with age. In addition, mesangial cell proliferation was increased, and the mesangial
matrix, which normally contains laminin-111, was greatly expanded. In vitro, mesangial cells from
Lama1CKO mice exhibited signiﬁcantly increased proliferation compared with those from controls. This
increased proliferation was inhibited by the addition of exogenous LAMA1-containing laminin-111, but
not by laminin-211 or laminin-511, suggesting a speciﬁc role for LAMA1 in regulating mesangial cell
behavior. Moreover, the absence of LAMA1 increased transforming growth factor (TGF)-b1einduced
Smad2 phosphorylation, and inhibitors of TGF-b1 receptor I kinase blocked Smad2 phosphorylation in
both control and Lama1CKO mesangial cells, indicating that the increased Smad2 phosphorylation
occurred in the absence of LAMA1 via the TGF-b1 receptor. These ﬁndings suggest that LAMA1 plays a
critical role in kidney function and kidney aging by regulating the mesangial cell population and
mesangial matrix deposition through TGF-b/Smad signaling. (Am J Pathol 2014, 184: 1683e1694;
http://dx.doi.org/10.1016/j.ajpath.2014.02.006)Supported by a Ministry of Education, Culture, Sports, Science, and
Technology (MEXT), Japan, Grant-in-Aid for Young Scientists (B)
24790860 (L.N.) and grants 17082008 and 2230023 (E.A.-H.), NIH
Intramural Program of the National Institute of Dental and Craniofacial
Research grant (Y.Y.), NIH grant R01DK078314 (J.H.M.), and
MEXTeSupported Program for the Strategic Research Foundation at Pri-
vate Universities (2011 to 2015).
Disclosures: None declared.Laminins comprise a family of heterotrimeric extracellular
matrix (ECM) proteins consisting of a, b, and g chains1,2
that regulate cell attachment, proliferation, and differentia-
tion.3,4 During early embryogenesis, laminin a1 (LAMA1)
ﬁrst appears at the 16-cell stage and is later present in the
two basement membranes (BMs) formed before gastrula-
tion, the embryonic BM, and Reichert’s membrane. In the
developing kidney, temporal changes in laminin isoform
expression occur as formation of glomeruli, the ﬁltering unit
of the kidney, proceeds. The earliest precursor of the
glomerular BM (GBM) contains laminin-111 (LM-111;
a1b1g1). In contrast, the GBM contains LM-521 (a5b2g1)
at later developmental stages and in adulthood. Althoughstigative Pathology.
.LAMA1 is absent from the mature GBM, it is present in the
glomerular mesangial matrix, an amorphous matrix made by
mesangial cells that is one of the few prominent sites in
which laminins are present outside of a deﬁnitive BM.5 The
glomerular capillary wall consists of podocytes with
Ning et alinterdigitated foot processes bridged by slit diaphragms,
glomerular endothelial cells, and the intervening GBM6 that
these two cell types together produce.7 Mesangial cells
(MCs), the third cell type of the glomerulus, comprise
approximately one-third of the glomerular tuft cell popula-
tion. MCs bind the GBM at the base of the glomerular
capillary loops to establish and maintain the structural ar-
chitecture of the glomerular capillaries,6 similar to the
function of certain microvascular pericytes. These cells also
contribute to mesangial matrix homeostasis, regulate ﬁltra-
tion surface area and capillary blood pressure, and phago-
cytose apoptotic cells and immune complexes formed at or
delivered to the glomerular capillaries. Cell biological and
biochemical studies have characterized MC responses to
hormones, cytokines, growth factors, and metabolic, in-
ﬂammatory, and immune mediators that are highly relevant
to primary glomerular diseases or to systemic diseases that
target glomerular cells.8
Because inactivation of the Lama1 gene in mice results in
a failure of assembly of Reichert’s membrane and devel-
opmental arrest shortly after implantation,9 in vivo studies of
LAMA1 function have been limited. Herein, we used a
conditional Lama1 knockout (KO) mouse model
(Lama1CKO) with speciﬁc deletion of Lama1 in the epiblast
lineage using Sox2-Cre to study the role of LAMA1 in
kidney development and function. We found that the
absence of LAMA1 delayed glomerular development, and
adult Lama1CKO mice developed focal glomerulosclerosis
and proteinuria with age. MCs from Lama1CKO mice
showed increased proliferation, resulting in expansion of the
mesangial cell compartment. Thus, LAMA1 plays a critical
role in MC homeostasis and kidney function.
Materials and Methods
Animal Experiments
Conventional Lama1 KO (Lama1del/del) mice die at approxi-
mately embryonic day 7 because of lack of Reichert’s mem-
brane.9,10 In a previous study, ﬂoxed Lama1 (Lama1ﬂox/ﬂox)
mice and heterozygous Lama1 null mice carrying the Sox2-
Cre transgene (Lama1del/þ; Sox2-Crecre/þ) were generated.11
Lama1CKO (Lama1ﬂoxed/del; Sox2-Crecre/þ) mice with a con-
ditional Lama1 deﬁciency, speciﬁcally in the epiblast, and its
derivatives, which comprise the entire embryo, were then
generated by crossing the two lines. Genotypes were
conﬁrmed by PCR of tail-snip DNA.11 Animals examined
included male and female mice, aged 1 day to 24 months.
Lama1ﬂox/ﬂox [wild-type (WT)] mice and Lama1ﬂox/del (het-
erozygous) mice were used as normal controls.
Immunoﬂuorescence
Kidneys from 7-month-old mice were ﬁxed with 4% PFA in
0.1 mol/L PBS, pH 7.4, overnight at 4C and then cry-
oprotected in 30% sucrose in PBS for 72 hours at 4C.1684Sections (4 mm thick) were cut with a cryostat and mounted
onto glass slides. For immunostaining, the frozen sections
were air dried and washed with PBS. The sections were
incubated with 0.1% Triton X-100 (Polysciences, Inc.,
Warrington, UK) in PBS for 15 minutes. After washing, they
were blocked with blocking buffer (5% normal donkey serum
and 2% bovine serum albumin in PBS) for 30 minutes and
incubated with dilutions of the primary antibody in the
blocking buffer for 1 hour. The following primary antibodies
were used: rabbit anti-laminin a1 (LAMA1)12; rabbit anti-
laminin a2 (LAMA2), rabbit anti-laminin a3 (LAMA3),
rabbit anti-laminin a4 (LAMA4), and rabbit anti-laminin a5
(LAMA5) (gifts from Dr. Takako Sasaki); rat anti-laminin g1
(LAMC1) (Chemicon International, Inc., Temecula, CA);
mouse anti-synaptopodin (Progen Biotechnik, Heidelberg,
Germany); rat anti-platelet endothelial cell adhesionmolecule
(PECAM; BD Pharmingen, Erembodegem, Belgium); and
rabbit anti-smooth muscle actin (Abcam, Cambridge, MA).
The slides were washed with PBS and incubated with the
secondary antibodies, Alexa 488 donkey anti-rabbit (Molec-
ular Probes, Eugene, OR), Cy3 donkey anti-mouse, and Cy
5econjugated donkey anti-rat (Jackson ImmunoResearch
Laboratories, Baltimore, MD) for 1 hour. In each experiment,
several sections were incubated without the primary antibody
to serve as controls. When the primary antibody was omitted
from the staining, no immunoreactivity was observed.
Histological and Morphometric Data
For histological data, mice were perfused with 4% para-
formaldehyde (PFA) under anesthesia. Kidney pieces from 2-
to 24-month-old mice were ﬁxed in 4% PFA and embedded in
parafﬁn.Sections (4mmthick)were deparafﬁnizedwith xylene,
hydrated in a graded series of ethanol, and washed with PBS.
For morphometric analysis of glomeruli, sections were
stained with either PAS or toluidine blue. Mesangial area was
quantiﬁed by a blind observer (L.N.). Fifteen glomeruli cut at
the vascular pole were randomly selected in PAS-stained
sections from each animal in each experimental group. The
increase in mesangial matrix (deﬁned as mesangial area) was
determined by the presence of PAS-positive and nuclei-free
areas in the mesangium; the glomerular area was also traced
along the outline of capillary loops using Imaging System
KS400 (Imaging Associates, Thame, UK).
For electron microscopy, small pieces of kidney cortex
from neonatal and 2- to 16-month-old mice were ﬁxed in
2.5% glutaraldehyde in PBS. Tissues were dehydrated and
embedded in plastic, and ultrathin sections were viewed
by transmission electron microscopy, as previously
described.13 GBM thickness at 15 months of age in three
Lama1CKOmice and three heterozygous mice was determined
by using the orthogonal intercept method.14 The degree of
foot process effacement was evaluated by foot process width.
A foot process was deﬁned as any connected epithelial
segment butting on the basement membrane between two
neighboring ﬁltration pores or slits. From each image, theajp.amjpathol.org - The American Journal of Pathology
LAMA1 Regulates Mesangial Matrixarithmetic mean of the foot process width was calculated, as








foot process is the total number of foot processes
counted in each image,
P
GBM length is the total GBM
length measured in each image, and the correction factor of
p/4 serves to correct for presumed random variation in the
angle of section relative to the long axis of the podocyte.
Urine Albumin and Creatinine Assays
At monthly intervals beginning at 4 months of age, mice
were placed in metabolic cages, and urine was collected for
24 hours. In some cases, 10 mL of urine in loading buffer
was analyzed on SDS-PAGE gels stained with Coomassie
Brilliant Blue. The urinary albumin-creatinine ratio was
determined by immunoassay (DCA Vantage Analyzer;
Siemens Healthcare Diagnostics, Deerﬁeld, IL).
Cell Culture
Glomeruli were isolated through the injection of magnetic
beads, which become trappedwithin glomerular capillaries.16
Brieﬂy, anesthetized 2-month-old mice were perfused with
8  107 Dynabeads M-450 (Invitrogen, Carlsbad, CA). The
kidneys were removed and minced on ice, followed by
digestion at 37C with 1 mg/mL collagenase and 100 U/mL
DNase I for 30 minutes, then ﬁltered twice with 100-mm
Falcon cell strainers (BD Falcon, Bedford, MA). The tissue
was pelleted by gentle centrifugation (200  g, 5 minutes),
and glomeruli containing Dynabeads were collected using a
magnetic particle concentrator (Dynal, Oslo, Norway) and
washed inHBSS three times. Isolated glomeruli were cultured
on type I collagen-coated culture dishes (BD BIOCOAT,
Bedford, MA) in Dulbecco’s modiﬁed Eagle’s medium sup-
plemented with 20% heat-inactivated fetal bovine serum, 100
mg/mL streptomycin, and 100 U/mL penicillin at 37C in a
humidiﬁed 95%/5% air/CO2 atmosphere. When primary
glomerular explant cultures reached day 30, cells were
washed with PBS and removed from dishes by trypsinization
(0.05% trypsin). Cells at passage 5 to 8were characterized and
used for the experiments. MCs cultured on chamber slides
were ﬁxed in 4% PFA and processed for immunoﬂuorescence
microscopy using antibodies for podocytes, endothelial cells,
and MCs, as described previously.17
Analysis of Cell Proliferation
MCs were seeded in 8-well chamber slides (5  103 cells
per well) and cultured with or without 5 mg/mL LM-111,
LM-211, or LM-511 (Biolamina, Sundbyberg, Sweden).
After 48 hours of culture, cell proliferation was assessed by
measuring the incorporation of 5-bromo-20-deoxyuridine
(BrdU) into cellular DNA by an immunoﬂuorescence assayThe American Journal of Pathology - ajp.amjpathol.org(Kit 1-1296736; Roche, East Sussex, UK). Cells were incu-
bated with 10 mmol/L BrdU (ﬁnal concentration) for 60 mi-
nutes before ﬁxation. The number of BrdU-positive cells was
counted and expressed as a percentage of the total number of
cells counted per ﬁeld. At least ﬁve separate ﬁelds per well
were examined. A negative control in which the anti-BrdU
primary antibody was omitted was also assayed in each trial.
RT-PCR and Real-Time PCR Analysis
Total RNA was extracted from the MCs with TRIzol re-
agent, according to the manufacturer’s instructions (Invi-
trogen). cDNA was synthesized from 2 mg of total RNA
using oligo dT primers (Invitrogen) and Superscript III
Reverse Transcriptase (Invitrogen). Real-time quantitative
PCR (qPCR) was performed using SYBR Green PCR
Master MIX and an ABI Prism 7500 Fast Sequence
Detection System (Applied Biosystems, Santa Clara, CA).
The primers used for transforming growth factor (TGF)-b1,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) am-
pliﬁcation were as follows: TGF-b1 50-ACCTTGGTAAC-
CGGCTGC-30 (forward) and 50-TCCTTGGTTCAGCCAC-
TGC-30 (reverse); and GAPDH 50-ACGGCAAATTCAAC-
GGCACAG-30 (forward) and 50-AGACTCCACGACATA-
CTCAGCAC-30 (reverse). Each sample was run in triplicate
and normalized to GAPDH expression.
ELISA Data
A sample of 1 N HCl (20 mL) was added to 100 mL of cell
culture supernatant and incubated for 10 minutes to activate
latent TGF-b1. After the supernatants were neutralized with
1.2 N NaOH/0.5 mol/L HEPES, the samples were analyzed
with a commercial TGF-b1 sandwich enzyme-linked
immunosorbent assay (ELISA; R&D Systems, Minneap-
olis, MN), according to the manufacturer’s recommenda-
tions. A standard curve was constructed using serial
dilutions of ultrapure human TGF-b1 (R&D Systems). The
amount of secreted TGF-b1 was normalized using total
cellular proteins. Each sample was measured in duplicate.
Western Blot Analysis
MCswere seeded at a density of 3 105 cells per dish, grown
to 70% conﬂuence, and cultured in the absence or presence of
5 mg/mL LM-111 for 24 hours. After serum starvation for 24
hours in the absence or presence of 5 mg/mL LM-111, cells
were treated with 10 ng/mL TGF-b1 (WAKO, Osaka, Japan)
for 30 minutes. To study the effect of TGF-b1 receptor I
(TbRI) kinase inhibitors on Smad2 phosphorylation, cells
were serum starved and treated with increasing concentra-
tions of SB-431542 (0.1, 1, 5, and 10 mmol/L) or dimethyl
sulfoxide (Sigma-Aldrich, St. Louis, MO) in the presence of
10 ng/mL TGF-b1 for 30 minutes.18 Protein extracts were
prepared in lysis buffer (Cell Signaling, Danvers, MA) con-
taining 1 mmol/L phenylmethylsulfonyl ﬂuoride, 10 mmol/L1685
Ning et alNa3VO4, and 2mmol/L NaF, as well as phosphatase inhibitor
cocktail. After incubation at 4C for 30 minutes, nuclear and
cellular debris were removed by centrifugation at 20,000 g
for 15 minutes at 4C. Protein was quantiﬁed by BCA assay
(Thermo Scientiﬁc, Rockford, IL) and 10 mg of protein per
lane was separated by SDS-PAGE.Western blot analysis was
performed as described previously.19 The primary antibody
used was antiephospho-Smad2 (Ser465/467) (1:1000; Cell
Signaling). The blots were subsequently reprobed with anti-
Smad2/3 (1:1000; Cell Signaling). For the TbRI and collagen
IV (COLIV) expression analysis, primary antibodies for
TbRI (1:1000; Abcam) and COLIV (1:1000; Abcam) were
used. The blots were subsequently reprobed with antieb-
actin antibody (1:1000; Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA). Horseradish peroxidaseelabeled secondary
antibody to rabbit IgG or mouse IgG (1:1000) was purchased
from GE Healthcare (Piscataway, NJ). Super Signal West
Dura Extended Duration Substrate (Thermo Scientiﬁc) was
used for detection of signals, and the images were captured
using LAS-3000 mini (Fujiﬁlm, Tokyo, Japan). Densitom-
etry analysis of band intensity was performed using Multi
Gauge version 3.0 (Fujiﬁlm).
Transfection
FuGENE HD (Promega, Madison, WI) was used for trans-
fection. Mesangial cells were plated on 6-well plates, grown
to 50% to 60% conﬂuence, and then transfected with either
pcDNA3.1-Lama1 or control pcDNA3.1. FuGENE HD
Transfection Reagent (3 mL) was added to the DNA solution
(1 mg in 100 mL Optimem). The mixture was incubated for
15 minutes at room temperature, then added to the cells. The
cells were treated with TGF-b1 for 24 hours after
transfection.
Statistical Analysis
Data are expressed as means  SEM. A two-sided Student’s
t-test was used for comparisons between two groups.
P < 0.05 was considered statistically signiﬁcant.
Results
Delayed Kidney Development in Lama1-Deﬁcient
(Lama1CKO) Mice
LAMA1 has been implicated in kidney development on the
basis of results from organotypic cultures.20,21 However, the
in vivo function of LAMA1 in kidney is unknown, primarily
because Lama1 KO mice die at early embryonic stages.
Herein, we used a viable conditional KO mouse (Lama1CKO)
model with a Sox2-Creemediated deletion of Lama1 spe-
ciﬁcally in the epiblast lineage, which produces all embry-
onic tissues.22 This enabled us to study the role of LAMA1 in
kidney development and function. We ﬁrst examined
developing nephrons in newborn Lama1CKOmice because all1686stages of nephrogenesis can be visualized in the newborn
cortex.22 We observed all appropriate developmental stages
in both control and Lama1CKOmice, including mesenchymal
condensates and comma-shaped bodies (data not shown), S-
shaped bodies (Figure 1, A and D), capillary loop stages with
forming glomerular capillaries (Figure 1, B and E), and
maturing glomeruli with blood cells in the capillaries
(Figure 1, C and F). We next quantitated the extent of
nephron/glomerular development for each developmental
stage in control and Lama1CKO mice as percentages of the
total (Figure 1G). The percentage of maturing and fully
mature glomeruli was signiﬁcantly decreased in Lama1CKO
mice compared with controls. These results showed that
glomerular development was delayed in Lama1CKOmice. To
investigate whether the delay in glomerular development
caused fewer nephrons in Lama1CKO mice, we measured
numbers of glomeruli in Lama1CKO and control kidneys from
2-month-old mice. We found that there was no signiﬁcant
difference in numbers of glomeruli between control and
Lama1CKO mice (Figure 1H).
Renal Abnormalities in Adult Lama1CKO Mice
Laminin isoform composition differs in GBM and in the
mesangial matrix, and it changes with glomerular develop-
ment.5,23 In some renal diseases, the normal transition and
ﬁnal composition are altered.22,24e28 Immunostaining
revealed that, in Lama1CKO mice, LAMA1 was absent from
the mesangium (Figure 2B), whereas it was expressed in
control mice (Figure 2A), as shown previously.5 LAMA2
was detected in the mesangium at a higher level in mutant
versus control (Figure 2, C and D), and LAMA4 was also
detected weakly in glomeruli of both control and Lama1CKO
mice (Figure 2, E and F). LAMA5 was detected in virtually
all GBM segments (Figure 2, G and H), in agreement with
previous studies.5 LAMC1 (g1) was detected in both the
GBM and the mesangium in control and in Lama1CKO
kidneys, but increased in the Lama1CKO mesangium
(Figure 2, I and J). These data show that even though
LAMA1 was absent from glomeruli, the distribution of the
other laminin a chains in glomeruli was similar to those of
normal mice, except for stronger immunostaining for
LAMA2 and LAMC1 in the mesangium of Lama1CKO mice.
Increased levels of LAMA2 and LAMC1 (as well as
perlecan; data not shown) in the mesangium indicated a
possible expansion of the mesangial compartment in
Lama1CKO kidneys. Histological examination by light mi-
croscopy revealed abnormalities in Lama1CKO mice
compared with the control exclusively in glomeruli. In
agreement with the immunoﬂuorescence, dividing kidneys
into sections (9 heterozygous, 1 WT, and 11 Lama1CKO
females at 7 months), followed by PAS staining, showed
mesangial expansion in Lama1CKO mice (Figure 3, AeD).
Mesangial expansion was quantitated by a morphometric
analysis; the PAS-positive and nuclei-free mesangial area in
the glomeruli of Lama1CKO mice was 44% more than that inajp.amjpathol.org - The American Journal of Pathology
Figure 2 Immunoﬂuorescence microscopic analysis of laminin chain
deposition. Basementmembranes andmesangial matrix were stainedwith anti-
laminin a1, a2, a4, and a5 (red), and anti-laminin g1 (green) antibodies, as
indicated. LMa1 is detected in the mesangial matrix in control mice (A) and is
absent in Lama1CKO mice (B). There are no detectable differences in laminin a
chain immunolocalization (CeJ), but LMa2 and LMg1 increase in themesangial
matrix in Lama1CKO mice (D and J). Original magniﬁcation, 400 (AeJ).
Figure 1 Histological characteristics of glomerular development. AeF:
Toluidine blueestained sections from newborn (post-natal day 1) mouse
kidneys.A and D: S-shaped body. A capillary loop is present in the cleft. B and
E: Capillary loop stage glomeruli showing the cup-shaped arrangement of the
podocytes. C and F: Mature glomeruli. The percentage of glomeruli at each
developmental stage in control and Lama1CKO mice. G: Signiﬁcantly lower
percentages of maturing and mature glomeruli are observed in Lama1CKO
kidneys (light gray bars) compared with the controls (dark gray bars).H: There
is no signiﬁcant difference in the number of glomeruli observed in Lama1CKO
versus control kidneys at 2 months of age. Data represent means  SEM.
*P < 0.05 versus control at same glomerular developmental stage. Original
magniﬁcation, 1000 (AeF). BC, Bowman’s capsule; CL, capillary loop; GC,
glomerular cleft; M, mesangial cells; P, podocyte progenitors.
LAMA1 Regulates Mesangial Matrixcontrol mice (Figure 3E). Total glomerular area was deﬁned
by tracing along the outline of the capillary loops and was
decreased in Lama1CKO mice compared with control mice
(Figure 3F). Thus, the relative mesangial area, as calculated
by determining the mesangial area/total glomerular area ratio,
was increased by 67% in the Lama1CKO mice (Figure 3G).The American Journal of Pathology - ajp.amjpathol.orgTaken together, these ﬁndings indicate that LAMA1 plays a
role in mesangial cell homeostasis and that other laminin a
chains cannot substitute for Lama1 in mediating this
function.1687
Figure 3 Light microscopy reveals renal abnormalities in adult
Lama1CKO mice. AeD: Representative images of PAS-stained kidney speci-
mens from 6- to 8-month-old control and Lama1CKO mice. C and D:
Glomerular size reduction and mesangial expansion are observed in
Lama1CKO mice. The graphs depict quantitative measurements of mesangial
area (E), glomerular area (F), and relative mesangial matrix area (G) of
control (dark gray bars) versus Lama1CKO (light gray bars) mice. H: The
average kidney weight relative to total body weight is shown. Data
represent means  SEM. *P < 0.05 versus control. Original magniﬁcations:
400 (A and C); 1000 (B and D).
Figure 4 Light microscopy reveals progressive development of glomer-
ulosclerosis in Lama1CKO mice. Representative micrographs of PAS- and H&E-
stained glomeruli in control and Lama1CKOmice aged 7, 15, and 23months (as
indicated). H&E staining shows matrix expansion in the Lama1CKO mouse
(DeF) compared with the control (AeC). E:At 14 to 16months, the Lama1CKO
CKO
Ning et alIn addition to the abnormalities in the mesangium, a
signiﬁcant difference in kidney weight between Lama1CKO
mice and control mice was observed, with the kidney weight
of Lama1CKO mice being lower than that of controls at 7
months of age (data not shown). These differences remained
signiﬁcant when values were normalized to body weight
(Figure 3H).mice showed moderate mesangial sclerosis. F: As the Lama1 mice aged,
mesangial sclerosis became more conspicuous. PAS staining revealed
increased mesangial cell proliferation and GBM thickening in the Lama1CKO
(JeL) compared with the control (GeI) mice. L: PASþ nodular mesangial
sclerosis was observed in Lama1CKOmice at 22 to 24months of age (arrow).M
and N: Quantitative measurements of mesangial cell number and relative
mesangial matrix area (per total glomerular tuft cross-sectional area) for
control (dark gray bars) and Lama1CKO (light gray bars) mice. Data represent
means  SEM. **P < 0.01, ***P < 0.001 versus control at same age;
yP < 0.05 versus 14- to 16-month-old mice; yyyP < 0.001 versus 6- to
8-month-old mice. Original magniﬁcation, 1000 (AeL).Lama1CKO Mice Develop Glomerulosclerosis with
Increased MC Proliferation and Mesangial Matrix
Expansion with Age
We next examined aging-associated glomerular pathological
features in Lama1CKOmice at 2 to 24 months of age. Before 6
months of age, no signiﬁcant renal histopathological changes1688were observed in either control or Lama1CKO mice (data not
shown). However, after 6 months of age, Lama1CKO mice
showed mesangial cell proliferation and mesangial matrix
expansion compared with control mice (Figure 4, DeF and
JeL). As Lama1CKO mice aged further, mesangial cell
numbers stayed the same, but mesangial matrix expansion
increased (Figure 4, M and N). By 6 to 8 months of age,
Lama1CKO mice showed a moderate mesangial matrixajp.amjpathol.org - The American Journal of Pathology
Figure 5 Electron microscopic analysis of glomeruli. Representative
electronmicrographs of control (A and C) and Lama1CKO (B andD) glomeruli at
14 to 16 months of age. Lama1CKO mice had signiﬁcant mesangial expansion
(asterisks) and GBM thickening (arrowhead). EeG: Quantitation of the
indicated features in control (dark gray bars) and Lama1CKO (light gray bars)
mice show signiﬁcant increases in mesangial cell number and GBM thickness
but no signiﬁcant difference was observed in podocyte foot process width.
Data represent means  SEM. **P < 0.01, ***P < 0.001 versus control.
Original magniﬁcations: 1000 (A and B); 10,000 (C and D).
Figure 6 Analysis of renal function.A:Urine from 3- to 24-month-old (M)
Lama1CKO and control mice was collected and analyzed by SDS-PAGE and
Coomassie Blue staining. The arrow denotes approximately 66 KDa, the size of
excreted albumin. Lama1CKO mice have a higher concentration of albumin as
they age compared with control mice. B: Urine was collected for 24 hours from
control (dark gray bars) and Lama1CKO (light gray bars) mice and analyzed for
albumin/creatinine ratio. Ratios in Lama1CKOmice are higher than in controls.
Data represent means SEM. *P< 0.05, **P< 0.01 versus control; yP< 0.05
versus 4- to 6-month-old mice and 8- to 10-month-old mice.
LAMA1 Regulates Mesangial Matrixexpansion, but they did not exhibit glomerulosclerosis
(Figure 4, D and J). By 14 to 16 months of age, 35% of
Lama1CKO mice showed numerous segmentally sclerosed
glomeruli (Figure 4E) associated with GBM thickening
(Figure 4K), whereas no control mice showed glomerulo-
sclerosis with GBM thickening (Figure 4, B and H). By 22 to
24 months of age, most Lama1CKO mice had many globally
and segmentally sclerosed glomeruli (Figure 4, F and L), and
PASþ nodular mesangial sclerosis was observed (Figure 4L).
Control mice also showed moderate mesangial expansion
and GBM thickening at this age, but only rarely showed
glomerulosclerosis (Figure 4, C and I). Glomerular abnor-
malities were characterized in more detail by electron mi-
croscopy in mice aged 14 to 16 months (Figure 5). In
agreement with light microscopy, there were more MCs and
an increased amount of mesangial matrix in old Lama1CKO
mice compared with controls (Figure 5B). Many areas of
GBM thickening were also observed (Figure 5D). These data
show that older Lama1CKO mice exhibit a greater degree of
MC and matrix irregularities versus controls, presumably
associated with aging.The American Journal of Pathology - ajp.amjpathol.orgDefects in Renal Function of Lama1CKO Mice
Because glomerular structure can inﬂuence glomerular
ﬁltration,6 the glomerular abnormalities in Lama1CKO mice
led us to look for alterations in renal function. Urine from
Lama1CKO and control mice was collected every 2 months
and analyzed (Figure 6). Coomassie Blue staining of urine
samples from Lama1CKO mice showed an increased level of
albumin compared with controls (Figure 6A). We also
consistently detected higher urinary albumin/creatinine ra-
tios in Lama1CKO mice at 6 to 24 months of age, and the
difference increased as the mice aged (Figure 6B). These
results demonstrate a progressive defect in the kidney’s
ability to handle albumin in Lama1CKO mice.MCs from Lama1CKO Mice Show Increased Proliferation
in Vitro
In vivo studies have provided evidence that LAMA1
deﬁciency promotes MC proliferation. To investigate this
further, we examined MC proliferation in vitro. Primary
cultures derived from mouse glomeruli yielded a homo-
geneous population of MCs (Figure 7, AeC). These were
characterized by their stellate/spindle-shaped morpholog-
ical features, positive staining for a-smooth muscle actin,
and negative staining for synaptopodin and PECAM,
which are speciﬁc for podocytes and endothelial cells,
respectively. MCs from Lama1CKO mice exhibited signif-
icantly increased proliferation compared with those from
control mice (Figure 7D).1689
Figure 7 Analysis of primary mesangial cells.
Mesangial cells are elongated, arranged in multiple
layers, and stained positively for smooth muscle a-
actin (A), but not synaptopodin (B) or PECAM (C).
D: Proliferation was assessed by immunoﬂuores-
cence assay for BrdU-positive cells as a percentage
of the total number of cells, averaged from ﬁve
separate ﬁelds of view. Mesangial cells from
Lama1CKO mice exhibit signiﬁcantly increased pro-
liferation compared with control cells. This increase
is inhibited by exogenous LAMA1-containing LM-
111, but not by LAMA2- or LAMA5-containing iso-
forms. E: Mesangial cell proliferation determined in
cells transfected with vector alone or with a LAMA1
expression vector. Control (dark gray bars) and
Lama1CKO (light gray bars) cells were cultured on
slide chambers for 24 hours and transfected for 48
hours before proliferation analysis. Restoration of
LAMA1 expression by Lama1CKO cells suppresses
their proliferation. Data represent means  SEM.
*P < 0.05, **P < 0.01 versus control; yP < 0.05
versus untransfected cells; zzP < 0.01 versus control
vector transfected cells.
Ning et alAfter this, we tested MC proliferation by treatment with
LM-111, LM-211, or LM-511. The increase in MC prolif-
eration was inhibited by exogenous LM-111, but not by
either LM-211 or LM-511 (Figure 7D). We also tested
whether LAMA1 deﬁciency is directly involved in this
increased MC proliferation by transfection of Lama1CKO
MCs with a Lama1 expression vector. RT-qPCR analysis
showed the expression of Lama1 mRNA in Lama1CKO MCs
transfected with the Lama1 vector (Supplemental
Figure S1B). We found that the expression of exogenous
Lama1 abrogated the increased proliferation of Lama1CKO
MCs, whereas the control empty vector did not (Figure 7E),
suggesting that LAMA1/LM-111 plays a speciﬁc role in
regulating MC homeostasis.
Loss of LAMA1 Increases TGF-b/Smad Signaling in
Lama1CKO MCs
TGF-b/Smad signaling is a major pathway involved in
renal ﬁbrosis.29 Binding of TGF-b1 to TbRII activates
TbRI kinase, which phosphorylates Smad2 and Smad3.
The phosphorylated Smad2 (p-Smad2) and p-Smad3 then
bind to Smad4 and form the Smad complex, which
translocates into the nucleus and regulates target gene
transcription.29 Smad7 is an inhibitory Smad that blocks
TGF-beinduced Smad-dependent ﬁbrosis. Because TGF-
b1 stimulates the synthesis and inhibits the degradation of
extracellular matrix molecules,30 and is associated with
increased mesangial matrix in several glomerular dis-
eases,30e32 we investigated the effect of the absence of
LAMA1 on TGF-b signaling. We ﬁrst examined the level1690of TGF-b1 mRNA and protein secreted in Lama1CKO
MCs. We did not detect signiﬁcant differences compared
with control MCs (Figure 8, AeC), indicating that the
absence of LAMA1 does not alter the levels of TGF-b1
expression. Next, we examined the levels of p-Smad2 in
the absence of LAMA1. The addition of TGF-b1 increased
p-Smad2 levels to a greater extent in Lama1CKO cells than
in control cells (Figure 8D), suggesting that the absence of
LAMA1 increases TGF-b/Smad signaling. The basal
phosphorylation level of Smad2 in Lama1CKO MCs was
higher than that in control MCs (Supplemental Figure S2)
when cells were cultured without serum starvation. In
addition, LM-111 treatment rescued the increased TGF-
b1einduced Smad2 phosphorylation in Lama1CKO cells,
implying that LAMA1 likely plays a direct role in
dampening the levels of TGF-b1emediated Smad2
phosphorylation in MCs. Furthermore, we sought to
elucidate the mechanism of increased Smad2 phosphory-
lation in the absence of LAMA1. MCs were pretreated
with SB431542, a speciﬁc and potent inhibitor of TGF-
beinduced phosphorylation of Smad2 by TbRI.33
SB431542 was added to the control and Lama1CKO cells
at varying doses, and cells were treated for 30 minutes
with TGF-b1. Cell lysates were collected and processed
for Western blot analysis of p-Smad2 levels. Decreased or
loss of Smad2 phosphorylation was observed in a dose-
dependent manner for both control and Lama1CKO cells
(Figure 8E). These data show that all of the phosphory-
lation of Smad2 occurs via the activity of TbRI, regardless
of the presence or absence of LAMA1. This indicates that
LAMA1 plays a direct role in limiting TGF-b/Smadajp.amjpathol.org - The American Journal of Pathology
Figure 8 TGF-b1/Smad signaling in mesangial cells from Lama1CKO and
control mice. A and B: TGF-b1 mRNA expression and secretion in mesangial
cells. MCs were cultured for 48 hours and serum starved for an additional 48
hours before total mRNA extraction and culture media collection. A: TGF-b1
mRNA expression levels measured by RT-qPCR. The bar graph represents the
ratio between the TGF-b1 and GAPDH levels. B: Immunoreactive TGF-b1
synthesis measured by ELISA. C: Western blot analysis of TbRI protein levels
in MCs. D and E: Smad2 phosphorylation determined by using Western blot
analysis. The intensity of signal was analyzed by Multi Gauge version 3.0
(Fujiﬁlm). Relative activity, expressed as the ratio of activated phospho-
Smad2/total Smad2/3, was quantiﬁed as the fold increase relative to
non-stimulation conditions (deﬁned as 1). MCs from control and Lama1CKO
mice were cultured in the absence or presence of 5 mg/mL LM-111 for 24
hours. D: After serum starvation for 24 hours, cells were treated with 10
ng/mL TGF-b1 (WAKO) for 30 minutes. MCs from control and Lama1CKO mice
were serum starved for 24 hours, followed by 1-hour treatment with
increasing concentrations of SB-431542 (0.1, 1, 5, and 10 mmol/L) or
dimethyl sulfoxide (DMSO), and then stimulated for 30 minutes with 10 ng/
mL TGF-b. E: Loss of Smad2 phosphorylation is observed in an SB-431542
dose-dependent manner for both control (dark gray bars) and Lama1CKO
(light gray bars) cells. Data represent means  SEM. **P < 0.01 versus
control; yP < 0.05 versus laminin-1 treatment cells; zP < 0.01 versus
control cells.
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enhanced activation of TGF-b signaling,34 we also
investigated Smad7 expression in MCs. There was no
signiﬁcant difference in the level of Smad7 protein in
control and in Lama1CKO cells (data not shown).
TGF-b1eInduced Type Ⅳ Collagen Expression Is
Increased in the Absence of LAMA1
Because Lama1CKO mice showed a thickened GBM
(Figure 5D), we examined the expression of COLIV, one of
the major mesangial matrix components.35 Immunostaining
analysis revealed more COLIV deposition in the mesangium
of Lama1CKO mice than of control mice (Figure 9A). Pre-
vious studies have shown that TGF-b1 induces COLIV
expression in mouse MCs.36 Therefore, we examined the
effect of TGF-b1 on COLIV expression in MCs prepared
from Lama1CKO mice. We found that TGF-b1 induced
COLIV expression in both control and Lama1CKO MCs, but
the level of COLIV expression was signiﬁcantly higher in
Lama1CKO MCs than in control cells (Figure 9, B and C).
This higher COLIV expression level in Lama1CKO MCs was
abrogated by transfection with the LAMA1 expression
vector, but not by transfection with the empty control vector
(Figure 9D). These results suggest that LAMA1 is involved
in the regulation of mesangial matrix production.Discussion
Our interest in LM-111 function in the kidney was initially
stimulated by the observation that Lama1 has a rather
restricted expression pattern. LAMA1 is found transiently in
the developing GBM, is absent in the mature GBM, and is
present in the glomerular mesangium in adult mice.5 Herein,
we demonstrated that Lama1 is critical for mesangial ho-
meostasis and kidney function.
An impediment to elucidating kidney LAMA1 function
had been that Lama1 disruption results in lethality at an
early embryonic stage.1 We previously described the gen-
eration of a conditional KO of Lama1 with selective dele-
tion only in embryonic cells, wherein the early embryonic
death observed in total Lama1 KO mice was overcome. Our
results demonstrate important functional roles for LAMA1,
which are exempliﬁed by delayed glomerular development,
abnormal renal histological features, and impaired renal
function. Increased MC proliferation and mesangial matrix
expansion are remarkable features observed in Lama1CKO
mice.
Diabetic nephropathy is histologically characterized by
thickening of the GBM and mesangial expansion.37e39 The
earliest morphological change in diabetic nephropathy is
mesangial expansion due to increased mesangial matrix
deposition and a mild increase in mesangial cellularity, as
well as hypertrophy of mesangial cells. The characteristic
histological changes of diabetic nephropathy are diffuse and1691
Figure 9 Expression of COLIV. A: The deposition of COLIV in the
glomeruli of control and Lama1CKO mice. Immunoﬂuorescence staining for
COLIV was performed in frozen tissue sections from 7-month-old mice.
BeD: Effect of TGF-b1 on COLIV synthesis by MCs. Control and Lama1CKO
MCs were cultured on slide chambers for 24 hours, serum deprived for an
additional 24 hours, and then treated with TGF-b1 for 24 hours. Immu-
noﬂuorescence (B) and Western blot analysis (C) were performed to analyze
COLIV synthesis and deposition. Values in C are expressed as COLIV/b-actin
and quantiﬁed as the fold increase relative to control non-stimulation
conditions (deﬁned as 1). Control and Lama1CKO MCs were cultured on
6-well plates for 24 hours and transfected for 48 hours before a 24-hour
TGF-b1 treatment. yP < 0.05 versus TGF-b1 treatment control cells. D:
COLIV protein levels were then determined by using Western blot analysis.
b-Actin was used as a control. The intensity of signal was analyzed by Multi
Gauge version 3.0 (Fujiﬁlm). The absence of LAMA1 increases TGF-
b1einduced COLIV expression. This increase was abrogated by transfection
of Lama1CKO (light gray bars) MCs with the LAMA1 expression vector;
control MCs are represented by dark gray bars. *P < 0.05, **P < 0.01
versus control; yP < 0.05 versus control vector transfected cells; zzP < 0.01
versus untransfected cells. Original magniﬁcation, 400 (A).
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1692nodular glomerulosclerosis, along with afferent and efferent
hyaline arteriolosclerosis. A reduction in podocyte number
is associated with foot process effacement.40 In the present
study, we observed GBM thickening, mesangial expansion,
and increased mesangial cell proliferation from 6-month-old
Lama1CKO mice. As the mice aged, there was increased
mesangial expansion due to glomerulosclerosis, which was
accompanied by progressive proteinuria. These pathological
conditions are similar to those seen in diabetic nephropathy,
but we did not observe differences between Lama1CKO and
control mice in terms of podocyte number or foot process
effacement. Although proteinuria was detectable in
Lama1CKOmice, this was at a lower level than in most kidney
diseases. Because there is no or little LAMA1 in the GBM,
podocytes would not be expected to have abnormalities. The
proteinuria in the later stages was likely due to mesangial cell
defects, which led to proﬁbrotic cross talk that affected the
podocytes, or perhaps due to some unknown mechanism.
Many studies have indicated that activated mesangial
cells are the major cells responsible for the expression of
interstitial matrix components, such as ﬁbronectin and type I
collagen, which directly result in mesangial expansion
leading to glomerulosclerosis.41 The present study demon-
strated that the deletion of LAMA1 results in age-dependent
mesangial expansion, which develops into focal glomer-
ulosclerosis. These observations lead us to hypothesize that
LAMA1 may be an endogenous negative regulator that
speciﬁcally suppresses mesangial cell activation.
TGF-b is the most potent cytokine inducing mesangial
cell activation both in vitro and in vivo.42 It stimulates the
expression of ECM proteins, including collagens, laminin,
and ﬁbronectin, while suppressing the synthesis of ECM
protease inhibitors.43 The Smad pathway is known to
mediate the functions of TGF-b on renal ﬁbrogenesis and
subsequent ECM accumulation in diabetic nephropathy.44
In the present study, we were unable to detect increased
TGF-b1 mRNA expression in Lama1CKO MCs. However,
an alternative mechanism is suggested from the increased
TGF-b1einduced Smad2 phosphorylation. In addition, in-
hibitors of TbRI kinase blocked Smad2 phosphorylation in
both control and Lama1CKO MCs. This supports the hy-
pothesis that LAMA1 suppresses mesangial cell activation
via inhibition of the TGF-b/Smad pathway.
Laminins not only function as structural components,
but also bind cell surface receptors, including integrins and
a-dystroglycan.45 We demonstrated that LM-111 treatment
abrogated the increased TGF-b1einduced Smad2 phos-
phorylation in Lama1CKO cells. Furthermore, the re-
storation of LAMA1 expression in Lama1CKO MCs by
transfection with the LAMA1 expression vector inhibited
the increased MC proliferation and TGF-b1einduced
COLIV expression. We, therefore, speculate that LM-111
synthesized by WT mesangial cells inhibits TGF-b1
signaling. TGF-b1 signals through its type I and type II
serine/threonine kinase receptors,42 and this pathway is
tightly controlled by multiple positive and negative regulatorajp.amjpathol.org - The American Journal of Pathology
LAMA1 Regulates Mesangial Matrixproteins.46 Negative regulation of TGF-b signaling is ac-
complished by the rapid attenuation or even inhibition of
TbRI/II and/or Smad activities.47,48 In extracellular com-
partments, decorin, a proteoglycan associated with matrix
components, binds to active TGF-b1 and prevents it from
engaging with its receptors.49 In cell membranes, integrin
signaling is involved in negatively regulating TGF-b
signaling, because adhesion reduces TGF-beinduced Smad2
phosphorylation.50Laminins regulate cellular behavior through
interactions with cell surface receptors, including integrins,
syndecans, anda-dystroglycan.1,51 In the cytoplasm, inhibitory
Smad7 either competeswith receptor-regulatedSmad to bind to
activated type I receptors or interacts with growth arrest and
DNA damage protein, a regulatory subunit of the protein
phosphatase 1 holoenzyme, which subsequently recruits cata-
lytic subunit of PP1 to dephosphorylate and inactivate the TGF-
b type I receptor.52
The present study demonstrated that excess Smad2
phosphorylation occurred in the absence of Lama1 via TbRI
and the absence of LAMA1 did not change the expression
of Smad7. In addition, the Biacore analysis and solid-phase
binding assays showed that the active form of TGF-b bound
to LM-111 (Supplemental Figure S3 and Supplemental
Table S1). This suggests that LAMA1 may play a direct
role in inhibiting TGF-b signaling by binding to active
TGF-b1 to prevent it from engaging with its receptors or by
interaction with integrin signaling, which is involved in
negatively regulating TGF-b signaling.
Taken together, our results suggest that LAMA1 plays a
role in negatively regulating TGF-b/Smad signaling. This
may be important for maintaining mesangial cell pop-
ulations and mesangial matrix deposition.Acknowledgments
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